Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.44 USD | +0.09% | +4.98% | +36.05% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.05% | 6.5B | |
+37.56% | 50.93B | |
-0.59% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.37% | 26.02B | |
-22.71% | 18.9B | |
+7.91% | 13.21B | |
+24.63% | 12.17B | |
+29.30% | 12.16B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Revolution Medicines Q1 Net Loss Narrows